MM Hipp, N Hilf, S Walter, D Werth… - Blood, The Journal …, 2008 - ashpublications.org
The tyrosine kinase inhibitors sorafenib and sunitinib are approved for the treatment of
patients with malignant diseases. To analyze the possible use of these compounds in …